Latest / Pharmacy Podcast Network / Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx

Transcript

Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx · Pharmacy Podcast Network

0:27
Speaker 1: Welcome to your Pharmacy podcast Network. Lots to talk about today,
0:37
Speaker 1: but first, Hi.
0:41
Speaker 2: This is Bruce neland I get to be the host
0:43
Speaker 2: of the Pharmacy Crossroads podcast. Pharmacy Crossroads is proud to
0:49
Speaker 2: be a member of the Pharmacy Podcast Network and I
0:53
Speaker 2: can't wait to listen to the next episode of This
0:57
Speaker 2: Week in Pharmacy.
1:00
Speaker 3: Hey, thank you Bruce so much for your commitment to
1:03
Speaker 3: the network for hosting Pharmacy Crossroads over the years. It's
1:08
Speaker 3: been absolutely terrific. Today we have Keith Kalmus, he's president
1:13
Speaker 3: of Nested Knowledge. We're gonna be talking about the impact
1:15
Speaker 3: of artificial intelligence on pharmacy practice. We're also gonna be
1:19
Speaker 3: talking with Jesse McCullough. Doctor McCullough wraps up the thirty
1:23
Speaker 3: one day Pharmacist Challenge and bonus guest Matthew Zachary. You're
1:29
Speaker 3: not gonna want to miss this one. This is gonna
1:31
Speaker 3: be incredible. We're going to be taking on the PBAM
1:35
Speaker 3: mafia all today on Twerks Halloween Special. Hey, welcome to
2:02
Speaker 3: twerks Hope you're having a great week. Hope you have
2:05
Speaker 3: some interesting plans for today. October thirty, first, twenty twenty five.
2:14
Speaker 3: It's Friday. It's time to toworks. It's going to be
2:16
Speaker 3: a big Friday out there throughout the communities. Definitely keep
2:21
Speaker 3: your ears and eyes open for the craziness. It's Halloween
2:24
Speaker 3: twenty twenty five. Come in on a Friday to kick
2:26
Speaker 3: off the weekend, and I can stress some people out,
2:32
Speaker 3: I know. And we've got trigger traders, and we got
2:35
Speaker 3: parties and we got people driving and masks and everything.
2:39
Speaker 3: So just have fun, but be careful. We have so
2:44
Speaker 3: much to go over today. I'm so excited that you're here.
2:47
Speaker 3: Thanks for listening to this Week in Pharmacy. First up,
2:51
Speaker 3: we're going to get into some tworks news. First, we're
2:58
Speaker 3: going to be talking about out the Flag the heads up,
3:06
Speaker 3: and that is coming from Pharmacy Practice News, and we're
3:11
Speaker 3: going to bring this one up first.
3:14
Speaker 4: Twerk's News from Pharmacy Practice News explores the appropriate use
3:17
Speaker 4: of the novel antibiotic Sephiderracle in combating multi drug resistant
3:21
Speaker 4: GRAM negative infections and the growing concern around emerging resistance.
3:25
Speaker 4: The drug uses a unique trojan horse mechanism, hitching a
3:28
Speaker 4: ride on bacterial iron transport pathways to overcome resistance mechanisms
3:32
Speaker 4: such as e flux pumps and beta lactamisases. Real world
3:35
Speaker 4: surveillance data and clinical trial follow ups suggest good activity
3:39
Speaker 4: against pathogens like pseudomonis and carbapenum resistant anenterobacterialities. However, the
3:44
Speaker 4: article emphasizes that sefiderocle's use must be paired with rigorous
3:47
Speaker 4: antimicrobial stewardship because resistance and treatment failure have already been
3:51
Speaker 4: documented in certain settings. Pharmacists play a key role in
3:54
Speaker 4: appropriate patient selection, monitoring, and ensuring optimal use to preserve
3:58
Speaker 4: its utility. The takeaway suffider rocle offers a promising option,
4:02
Speaker 4: but only if used judiciously, not as a first line
4:05
Speaker 4: broad agent, and only within frameworks that guard against further resistance.
4:11
Speaker 5: Now in October thirtieth, this week in pharmacy news from
4:14
Speaker 5: Specialty Pharmacy Continuum reports how alternative funding programs arrangements used
4:18
Speaker 5: by self insured employer health plans to shift specialty drug
4:21
Speaker 5: costs outside standard pharmacy or medical benefits are increasingly influencing
4:26
Speaker 5: access to specialty medications. AFPs typically exclude high cost specialties
4:30
Speaker 5: from benefit coverage, directing patients to third party vendors who
4:33
Speaker 5: attempt to leverage manufacturer or charitable assistance programs, while employers
4:38
Speaker 5: may see cost saving appeals. The article highlights risks delayed treatment,
4:42
Speaker 5: higher out of pocket costs, and burdened assistance programs originally
4:45
Speaker 5: aimed at uninsured or low income populations. Evidence indicates AFPs
4:50
Speaker 5: may reduce transparency, undermined benefit design, and potentially bypass regulatory
4:54
Speaker 5: oversight that governs traditional insurance. The bottom line, AFPs present
4:58
Speaker 5: a growing access barrier for patients with rare or complex conditions,
5:02
Speaker 5: shifting cost burdens and complicating care coordination.
5:06
Speaker 3: Shout out to specialty pharmacy continuing thank you for the
5:09
Speaker 3: news today. We're going to be doing more with you
5:12
Speaker 3: in twenty twenty six. This next news is a big one.
5:16
Speaker 3: You've probably already heard about it.
5:18
Speaker 6: An alarming update today from the Associated Press. A nationwide
5:21
Speaker 6: recall has been issued for nearly six hundred thousand bottles
5:24
Speaker 6: of the blood pressure medication Prosessin hydrochloride following detection of
5:28
Speaker 6: a potentially cancer causing nitrosimen impurity called N nitrosoprozisin impurity C.
5:33
Speaker 6: According to the Food and Drug Administration, the batches in
5:35
Speaker 6: question were produced by Teva Pharmaceuticals USA and were voluntarily
5:39
Speaker 6: recalled in multiple strengths and bottle sizes. The recall is
5:42
Speaker 6: classified as Class two, meaning the drug may cause temporary
5:45
Speaker 6: or medically reversible adverse health issues, but the risk of
5:48
Speaker 6: serious harm is considered remote. Patients currently taking the recalled
5:51
Speaker 6: medication are urged not to stop the drug abruptly. Instead,
5:54
Speaker 6: they should check with their pharmacy and or healthcare provider
5:57
Speaker 6: to verify whether their lot is affected and discuss safe
6:00
Speaker 6: alternative therapies. Pharmacists are in a key role to help
6:03
Speaker 6: identify impacted lots, advise patients, and coordinate product replacement or
6:07
Speaker 6: therapeutic substitution.
6:10
Speaker 3: All Right, in rounding out Twark's news today, were digging into.
6:14
Speaker 7: The last story on today's twerux news is from Pharmacy
6:17
Speaker 7: Times titled Meeting Patients where they Are How pharmacists are
6:20
Speaker 7: helping people stay on track with schizophrenia treatment. The article
6:23
Speaker 7: highlights a pharmacists led program by Genoa Healthcare which focuses
6:27
Speaker 7: on improving medication adherents for patients with schizophrenia by addressing
6:30
Speaker 7: the transition from hospital to community care, a high risk
6:33
Speaker 7: gap in the care continuum. Long acting injectables are used
6:36
Speaker 7: as a strategic tool to offer consistent medication delivery, reducing
6:39
Speaker 7: relapse and hospitalization risk in schizophrenia. Genoa's model embeds pharmacists
6:44
Speaker 7: in mental health center clinics, verifies insurance authorization prior to discharge, schedules,
6:48
Speaker 7: next injections proactively, and follows up if patient's misappointments. Since
6:52
Speaker 7: the program launch in twenty twenty three, they have administered
6:54
Speaker 7: over fifty thousand LA doses across more than seven hundred
6:57
Speaker 7: and forty pharmacy locations in forty seven states, demonstrating scalable impact.
7:01
Speaker 7: Pharmacists are positioned as accessible, trusted members of the care
7:04
Speaker 7: team who can bridge complex access barriers like cost, logistics,
7:07
Speaker 7: and education. The model shows that proactive, integrated pharmacy based
7:11
Speaker 7: interventions can support better outcomes and not just medication dispensing.
7:15
Speaker 7: This approach underscores expanding roles for pharmacists in behavioral health,
7:19
Speaker 7: especially in community or clinic based settings.
7:22
Speaker 3: Hey, if you have anything that you'd like to share
7:26
Speaker 3: on twrque's news. If you're a news organization, if you're
7:28
Speaker 3: a company and you want to share this, please reach
7:31
Speaker 3: out to us. Reach out to me at ur EU
7:34
Speaker 3: r Y at Pharmacy podcast dot com and before we
7:39
Speaker 3: get into our first feature, we'll be right back. Hey everyone,
7:49
Speaker 3: it's Todd Uri with the Pharmacy Podcast Network. I could
7:52
Speaker 3: not be more excited to talk to you that we're
7:54
Speaker 3: going to be doing the Surecast with sure Cost at
7:58
Speaker 3: the Insights User comp It's on November thirteenth and fourteenth.
8:02
Speaker 3: I'm going to be part of this event. I cannot
8:04
Speaker 3: wait to meet with you, talk with you, leverage data together,
8:09
Speaker 3: learn how to use data better. And it's going to
8:12
Speaker 3: be an incredible opportunity to connect with other pharmacy owners
8:15
Speaker 3: and innovators, colleagues who are all working together for the
8:18
Speaker 3: same goal helping pharmacies thrive. And what better way to
8:22
Speaker 3: capture those conversations than a live event that's sure Cast
8:27
Speaker 3: and I can't wait to bring this to you, sit
8:29
Speaker 3: down with so many of you. This is going to
8:31
Speaker 3: be in Nashville, don't forget on November thirteenth through fourteenth,
8:35
Speaker 3: and there will be a lenk to go to the
8:38
Speaker 3: registration and we'll see you there.
8:50
Speaker 8: Asking farmacy, it's so scary dayan Halloween line here at
8:59
Speaker 8: the Fall Podcast. Nit.
9:01
Speaker 3: WHOA is that scaring anybody? Is this mask s hearing anybody?
9:07
Speaker 3: This mask scares the crap out of me. I don't
9:10
Speaker 3: even want to look at it on camera. Hey, we
9:13
Speaker 3: have a special guest. He is currently invisible. You can't
9:17
Speaker 3: even see him up against the brick wall, but he
9:21
Speaker 3: is a ghost and he's floating around out there because
9:24
Speaker 3: I want to demystify and make AI less invisible than
9:29
Speaker 3: what it is, because I want to understand it better.
9:31
Speaker 3: Keith Calumus from Nesting, Happy Halloween, Happy Halloween. I might
9:39
Speaker 3: get the stupid mask off of my head now and
9:42
Speaker 3: start the show. This is This is a good day.
9:44
Speaker 3: How are you.
9:45
Speaker 9: I'm doing very well. It's a beautiful day.
9:48
Speaker 3: What are you gonna do for Halloween tonight? Anything.
9:51
Speaker 9: I'm gonna go to a conference and then I'm gonna
9:53
Speaker 9: fly to Italy and then I'm gonna go to another conference.
9:56
Speaker 3: Yeah, you have been conferencing everywhere. What conferences happen in Italy?
10:02
Speaker 3: I'm so.
10:03
Speaker 9: I was just at AVBCC Association of Value Based Cancer Care.
10:06
Speaker 9: I'm going to AMCP Nexus and then I'm going to
10:10
Speaker 9: Italy to see my sister, and then I'm going to Isborn.
10:13
Speaker 10: Right from there to Ispor Scotland.
10:15
Speaker 9: So I have four conferences in five weeks. Italy is
10:18
Speaker 9: my week off to spend with my family and then
10:20
Speaker 9: it's just back to back to back.
10:22
Speaker 3: That's incredible. That's a lot, a lot of work, a
10:24
Speaker 3: lot of travel, but you are heating up. I met
10:27
Speaker 3: you at a conference recently, just earlier this year understood
10:32
Speaker 3: what nested knowledge is doing to impact healthcare more specifically pharmacy,
10:37
Speaker 3: especially pharmacy and in the use of accelerating AI into
10:41
Speaker 3: practice and usage. And I'm excited to feature you again
10:46
Speaker 3: on this Week in Pharmacy. I want you to give
10:49
Speaker 3: our listeners just a short overview if they haven't heard
10:52
Speaker 3: some of our previous episodes. What is nested knowledge tell
10:56
Speaker 3: us about that?
10:58
Speaker 9: That's a great question. Nested knowledge, in brief is evidence
11:03
Speaker 9: synthesis for pharmaceutical and health care providers.
11:10
Speaker 10: It's a means and a.
11:11
Speaker 9: Method for taking all of the literature that exists, compiling
11:15
Speaker 9: and analyzing it in as efficient and comprehensive a way
11:20
Speaker 9: as possible. That includes things like systematic literature reviews, meta analyses,
11:25
Speaker 9: targeted reviews, gap assessments all the way up to like
11:28
Speaker 9: a health technology assessment dossier. For those of you in
11:31
Speaker 9: the United States like me, something like an a MCP dossier.
11:35
Speaker 9: So when a pharmaceutical company wants to get reimbursed, they
11:41
Speaker 9: need to show number one, the unmet clinical need or
11:44
Speaker 9: the additional clinical utility of a drug. They need to
11:47
Speaker 9: show the epidemiological burden of illness of the disease that
11:50
Speaker 9: they're seeking to treat or manage. And they need to
11:53
Speaker 9: show economic impact, so how much they're going to benefit
11:56
Speaker 9: the hospital system or the patient with patient as family,
12:01
Speaker 9: or the society in general. So clinical, epidemiological, and economic benefit,
12:05
Speaker 9: and that goes into a dossier. And for you pharmacists
12:10
Speaker 9: out there, all this is upstream of formulay. All this
12:13
Speaker 9: is upstream of when you're actually able to prescribe a drug.
12:17
Speaker 9: Evidence synthesis is also key for things like designing real
12:20
Speaker 9: world evidence protocols. That's what I'm going to be speaking
12:22
Speaker 9: on at AMCP and NEXUS this week. It's also central
12:25
Speaker 9: to regulatoic submissions, knowing the existing landscape that's out there.
12:29
Speaker 9: It's also central to designing clinical trials so you can
12:32
Speaker 9: align your protocols with previous clinical trials and really optimize
12:35
Speaker 9: that meta analysis coming down the pipe. It's central to
12:37
Speaker 9: healthcare decision making, no matter what stakeholder you are, and
12:41
Speaker 9: we're really in an exciting time. It used to be,
12:44
Speaker 9: you know, entirely manual. Used to be you went to
12:45
Speaker 9: a physical library to do it. Then it was you
12:47
Speaker 9: went to PubMed and pulled things down manually and did
12:49
Speaker 9: it an excel. And we're now entering the AI age
12:52
Speaker 9: of evidence synthesis, where you know you can do things
12:55
Speaker 9: eighty five ninety percent faster and than you could just
12:57
Speaker 9: two or three years ago.
12:59
Speaker 3: I like and I like the fact that you are
13:03
Speaker 3: going full steam ahead. We've here. I've heard from pharmacists.
13:07
Speaker 3: I've heard from pharmacy owners that they say, does AI
13:12
Speaker 3: present a threat to the value of our clinicians, to
13:16
Speaker 3: our pharmacists and for me, in what little I know
13:20
Speaker 3: from what I've seen different tools in usage, including nested
13:24
Speaker 3: knowledge impact on our publication through some of the projects
13:27
Speaker 3: that we're working on that we're going to be releasing
13:30
Speaker 3: full steam and twenty twenty six, the answer is no.
13:34
Speaker 3: It's it's a it's an amplifier for an existing in
13:39
Speaker 3: existing talent and existing experience, and your team is bringing
13:44
Speaker 3: so much research to the fingertips into the eyes and
13:48
Speaker 3: ears of our clinicians through through what you've designed. We're
13:53
Speaker 3: excited about this. Can you give us some examples? Because
13:57
Speaker 3: you and I met at Asembia twenty twenty five five
14:00
Speaker 3: earlier this year, can you give us some examples of
14:03
Speaker 3: how nested knowledge is working. Let's say in specialty pharmacy,
14:07
Speaker 3: for example.
14:08
Speaker 9: Absolutely, so the first thing that pops in my mind
14:11
Speaker 9: because we met it in Vegas, but then we caught
14:14
Speaker 9: up in Denver at NASP. Something a specially pharmacists would
14:20
Speaker 9: use does use NSTA knowledge for would be just seeing
14:23
Speaker 9: what specialty drugs are coming down the pipe, right, So
14:26
Speaker 9: this could be novel molecules, it could be biosimilars or generics.
14:30
Speaker 9: Every single manufacturer that wants to sell their products in
14:36
Speaker 9: the United States is going to have a clinical trial
14:38
Speaker 9: stuct of registration for their phase one, two three trials
14:42
Speaker 9: that they're running to get that drug on the market,
14:45
Speaker 9: and specially pharmacists have every incentive to know what that
14:48
Speaker 9: pipeline looks like. You know, one, maybe you're looking to
14:52
Speaker 9: grow your formula. Maybe there's a new molecule that's coming
14:54
Speaker 9: down the pipe that will lead to a more competitive
14:57
Speaker 9: market and better pricing for you and your patients. Number Two,
15:00
Speaker 9: if if you're trying to secure a new important drug
15:06
Speaker 9: for your specialty pharmacy in competition with other specialty pharmacies
15:11
Speaker 9: in the area and they're only going to do it
15:13
Speaker 9: with one or two specialty pharmacies, knowing which manufacturers are
15:17
Speaker 9: at what point in development for those molecules can be
15:19
Speaker 9: extremely helpful, and you could just use nested knowledge to
15:22
Speaker 9: automatically pull every trial in any given therapeutic area diabetes
15:30
Speaker 9: and obesity, oncology, Crohn's disease, ultratate ladies, et cetera, into
15:36
Speaker 9: a database and within you know, ten to fifteen minutes,
15:40
Speaker 9: have a view of the landscape, who's developing, what the sponsors,
15:43
Speaker 9: the phase, the target patient populations, and that could even
15:47
Speaker 9: translate down the line into comparative efficacy data.
15:50
Speaker 10: So if you're.
15:52
Speaker 9: A pharmacist that's working in P and T because it's
15:55
Speaker 9: you know, MCP next this week, I have to drop
15:58
Speaker 9: the P and T aspect of this. When you're looking
16:02
Speaker 9: at what drug should be un formulary, you want to know, hey,
16:04
Speaker 9: is this going to serve my patients, and very swiftly,
16:08
Speaker 9: with a nested DOALAD you can actually get meta analytical
16:11
Speaker 9: comparative clinical efficacy data to establish non inferiority or superiority
16:15
Speaker 9: of a new molecule, whereas in the past, you know,
16:18
Speaker 9: that would have taken a biostatistician something like nine months
16:21
Speaker 9: and hundreds of thousands of dollars to do. So that's
16:24
Speaker 9: that's how a specially pharmacists would use us. The last
16:27
Speaker 9: one I can think of is just for your curiosity.
16:29
Speaker 9: You know, if you ever just have this idea, I
16:31
Speaker 9: wonder what the standard of care for this therapeutic area
16:35
Speaker 9: is and you want to know. You know, that used
16:37
Speaker 9: to be a sort of shot in the dark with PubMed.
16:40
Speaker 9: Now you can do it in again minutes and get
16:42
Speaker 9: the get an AI summary in an AI landscape of
16:46
Speaker 9: you know what what drugs are used for, what patient
16:50
Speaker 9: populations in what in what therapeutic area is So yeah,
16:53
Speaker 9: actually I'm gonna haved one more comment on that around
16:56
Speaker 9: what you were saying with what how is AI going
16:58
Speaker 9: to affect practice? We are an enablement technology, we're human
17:03
Speaker 9: in the loop technology. There's a lot of really cool
17:05
Speaker 9: aias out there that are just sort of like chatbots
17:07
Speaker 9: or you can ask them questions and they'll give you references,
17:09
Speaker 9: and I use those lll ms every day. I think
17:11
Speaker 9: they're great tools, But when it comes to you know,
17:16
Speaker 9: systematic decision making, I think is really important that we
17:19
Speaker 9: have humans in the driver's seat, and what we really
17:22
Speaker 9: try to do is automate scutwork, automate the you know,
17:25
Speaker 9: formatting and extraction, so the humans can focus on human
17:29
Speaker 9: level decision making. And some preliminary data we're we're seeing,
17:34
Speaker 9: you know, eighty five plus percent time savings versus manual
17:37
Speaker 9: We've improved accuracy, and I actually think that the latter
17:39
Speaker 9: piece is more important. AI can not only save you time,
17:42
Speaker 9: that can actually make you more comprehensive and more accurate
17:44
Speaker 9: in your in your research.
17:46
Speaker 3: I also like the fact that if you had a
17:49
Speaker 3: disease state let's say we're looking at a blood disorder,
17:52
Speaker 3: we have hyper lipidemia, we have many medications that have
17:56
Speaker 3: been leveraged at different times of treatment, maybe at the beginning,
17:59
Speaker 3: middle state, ongoing, something that you're able to do for
18:04
Speaker 3: the clinician teams and and drill down into as you say, hey,
18:08
Speaker 3: what are the medications, what are the studies, What are
18:12
Speaker 3: some of the recent studies that support what I'm looking for,
18:16
Speaker 3: and you might dial into in the in the scouting.
18:19
Speaker 3: I love that word, the scouting is and now it
18:21
Speaker 3: goes out into into where it can to find that information.
18:26
Speaker 3: I think this becomes more powerful as we start connecting
18:29
Speaker 3: some of nested knowledge's systems and interfaces to drug database repositories,
18:37
Speaker 3: information repositories like a Walter's Clue or a big medi
18:42
Speaker 3: span or something, so that we can source, source, source
18:45
Speaker 3: and bring things faster to a clinician. And therein lies
18:50
Speaker 3: also which you said, uh, which is using it as
18:56
Speaker 3: a way to empower the clinician, But it's up to
18:58
Speaker 3: the clinician. It's a clinical decision making. We're not taking
19:02
Speaker 3: anything away from the clinician. We're just giving so much
19:05
Speaker 3: more faster accessibility of information that they are usually having
19:10
Speaker 3: to research on their own or sub it out to
19:13
Speaker 3: someone else to do that research. And I think that
19:17
Speaker 3: the novelty as well as the current event of things
19:22
Speaker 3: that are happening in the markets as well as in
19:24
Speaker 3: specific disease state management is just fascinating of how a
19:28
Speaker 3: nested knowledge system can assist. So this is powerful. Up
19:32
Speaker 3: to data, if you will, up to data exactly. I
19:36
Speaker 3: love it. I can't believe it. You are going to Italy.
19:40
Speaker 3: Have you ever been to Italy before?
19:41
Speaker 9: I have thee ided venice in Rome, but I'm doing
19:43
Speaker 9: Florence this time, so it should be fun.
19:46
Speaker 3: Yeah. Well, we want to hear about it, so maybe
19:49
Speaker 3: when you get back you can spend some more time
19:51
Speaker 3: with us. We're going to bring on a pharmacist with
19:53
Speaker 3: you or maybe even a couple that are interested in
19:57
Speaker 3: leveraging AI, as well as maybe some of the organizations
20:01
Speaker 3: and people that you've worked with in the past, so
20:03
Speaker 3: that they can start building contextual comparison of what nested
20:07
Speaker 3: Knowledge has done to amplify, to speed up, to support
20:13
Speaker 3: our pharmacists, clinicians and dialing into better patient care. This
20:19
Speaker 3: is fascinating, excellent all look Yeah, Happy Halloween. I hope
20:25
Speaker 3: you get some trick or treat candy tonight and and
20:28
Speaker 3: and have a safe trip to Italy.
20:31
Speaker 9: Happy Higoween, Todd, thanks so much for having me on.
20:34
Speaker 3: Hey, we will be right back with more Twarks.
20:42
Speaker 11: As frontline healthcare providers, pharmacists like you understand the importance
20:46
Speaker 11: of personalized care, especially in acute pain management. You role
20:50
Speaker 11: Pharma is dedicated to providing high quality, generic products tailored
20:54
Speaker 11: to meet your patient's needs. The company aims to serve
20:58
Speaker 11: a diverse range of patient population, including athletes recovering from
21:02
Speaker 11: intense training, weekend warriors, managing minor injuries, and those seeking
21:06
Speaker 11: a practical and mess free option for acute pain management.
21:10
Speaker 11: Keep your all in your toolbox of pain management options
21:13
Speaker 11: and join the ranks of pharmacists leading away in personalized care.
21:17
Speaker 11: To learn more about you Ral Pharma and its products,
21:20
Speaker 11: including full prescribing information, boxed warnings, and important safety information,
21:25
Speaker 11: visit Eurylpharma dot com That's why a rl Pharma dot
21:31
Speaker 11: com and connect with them on LinkedIn.
21:37
Speaker 12: Hello Pharmacy Podcast Network, and welcome back to the thirty
21:41
Speaker 12: one day American Pharmacist Month Challenge. I'm your host, Jesse McCullough,
21:45
Speaker 12: and here we are. We are on the last day
21:49
Speaker 12: of the thirty one day Challenge. I got to start
21:51
Speaker 12: off just by saying thank you. I cannot tell you,
21:54
Speaker 12: I can't even put into words how thankful I am
21:58
Speaker 12: to everybody who has participate into this challenge. I can't
22:01
Speaker 12: put into words how thankful I am for all the
22:04
Speaker 12: guests that have come on the challenge to share these
22:06
Speaker 12: just different, wonderful challenges. I really wish I could pick
22:09
Speaker 12: out what my favorite challenge has been over the course
22:12
Speaker 12: of the last thirty one days, and of course being
22:15
Speaker 12: here with a special sort of bonus challenge if you will,
22:19
Speaker 12: on the Pharmacy Podcast Network. Let me also just say
22:23
Speaker 12: thank you so much to the Pharmacy Podcast Network for
22:26
Speaker 12: giving me this platform to share these extra challenges with you,
22:30
Speaker 12: my colleagues and brothers and sisters in the world of pharmacy.
22:35
Speaker 12: I hope you have found some value in any of
22:38
Speaker 12: all the challenges that you have participated in over the
22:41
Speaker 12: course of the Over the course of the last month,
22:45
Speaker 12: I've spent a lot of time this evening just thinking
22:48
Speaker 12: what's the last challenge that I share with you, the
22:54
Speaker 12: viewers and listeners of the Pharmacy Podcast Network. And I've
22:58
Speaker 12: gone back and forth. I said, well, maybe I'll even
22:59
Speaker 12: give a challenge. I mean, the last official challenge dropped
23:02
Speaker 12: this morning at six am. Maybe you don't even have
23:06
Speaker 12: the appetite for another challenge. And I thought, well, maybe
23:11
Speaker 12: maybe it's something like this. Maybe maybe it's not so
23:15
Speaker 12: much a challenge as it is an invitation. Maybe maybe
23:19
Speaker 12: it's an invitation that as we bring American Pharmacist Month
23:22
Speaker 12: to a close, maybe we need to have an invitation
23:25
Speaker 12: so that when we get back to American Pharmacist Month
23:28
Speaker 12: in twenty twenty six, we can say, wow, look.
23:31
Speaker 3: At all of the ground we have covered.
23:35
Speaker 12: Now, I want to share with you a story that
23:38
Speaker 12: my mentor, Mark Cole shared with me several years ago. Now,
23:45
Speaker 12: Mark said, Jess, everyone deserves to be led well. And
23:51
Speaker 12: for those of you that aren't real familiar with, you know,
23:53
Speaker 12: my space in the world of pharmacy. My space is
23:57
Speaker 12: to help pharmacists improve their leadership skills so that they
23:59
Speaker 12: can lead themselves, their teams, and their patients better. And
24:05
Speaker 12: way back, you know, several years ago, Mark said to me, Jess,
24:10
Speaker 12: everyone deserves to be led well, and that that just
24:14
Speaker 12: seemed that seemed pretty steep to me at the time.
24:17
Speaker 12: And the way that I had to wrestle with that
24:21
Speaker 12: is I had to sort of turn it upside down
24:23
Speaker 12: and I had to well, I said, well, maybe maybe
24:26
Speaker 12: not everybody deserves to be led.
24:28
Speaker 1: Well.
24:28
Speaker 12: Let me make a list of those people who deserve
24:32
Speaker 12: to not be led well, Like, who are the folks
24:34
Speaker 12: that we can get away with leading poorly? And I
24:38
Speaker 12: sat there with a blank piece of paper, and after
24:42
Speaker 12: quite a bit of time. I had to sort of
24:44
Speaker 12: concede that I couldn't put any name on that list
24:48
Speaker 12: right now. I don't know what area of the world
24:51
Speaker 12: of pharmacy that you where you operate in, but I'm
24:55
Speaker 12: going to tell you the people that you work with,
24:57
Speaker 12: every one of them deserves to be led, well, every
25:02
Speaker 12: one of them. It doesn't it doesn't matter what's going on.
25:04
Speaker 12: They all deserve to be led well. They all they
25:06
Speaker 12: all deserve to define themselves in a better situation, you know,
25:10
Speaker 12: after they've had a conversation with you than before.
25:13
Speaker 3: Right.
25:14
Speaker 12: So, I think that's what I want to give you today.
25:17
Speaker 12: And if you want to, you know, make this a challenge,
25:19
Speaker 12: you can make this a challenge. But I would encourage
25:22
Speaker 12: you to write these words down, and it's that everyone
25:26
Speaker 12: deserves to be led well. And you know, I would
25:29
Speaker 12: go so far if you if you really need to emphasize,
25:31
Speaker 12: feel free to underline any or all of those words. Right,
25:35
Speaker 12: everyone deserves to be led well. Now the invitation comes
25:42
Speaker 12: from this. It's so while we can, we can agree,
25:46
Speaker 12: and I think we could probably come to relatively quick
25:48
Speaker 12: agreement that everyone deserves to be led well. I think
25:53
Speaker 12: we can look and we can see that there's a
25:54
Speaker 12: lot of people who aren't. I think we can find
25:57
Speaker 12: evidence of people who, you know, they find themselves in
26:02
Speaker 12: a place of struggle because they are not being led well.
26:06
Speaker 12: And to that end, let me invite you, dear listener,
26:11
Speaker 12: Let me invite you, dear viewer, however it is that
26:13
Speaker 12: you're consuming this episode of this Week in Pharmacy, let
26:17
Speaker 12: me invite you to be part of a community where
26:20
Speaker 12: we improve our leadership skills. Now, you may already have
26:24
Speaker 12: a plan, and I certainly hope that you do have
26:26
Speaker 12: a plan to improve your leadership skills. So just that
26:28
Speaker 12: in my experience, the overwhelming majority of people don't. In
26:34
Speaker 12: my experience, pretty much less than five percent of people
26:38
Speaker 12: have any type of plan to do that. And so
26:43
Speaker 12: to that end, I want to invite you into a
26:44
Speaker 12: community where you can begin to build those build those skills,
26:50
Speaker 12: and you can begin to understand the principles and the
26:53
Speaker 12: foundations that are going to allow you to lead people well. Again,
26:57
Speaker 12: everyone deserves to be led well. And so I'm going
27:02
Speaker 12: to send Todd. I'm going to send you the link. Right,
27:06
Speaker 12: I'm gonna ask that you share this link out with
27:09
Speaker 12: with with this episode of this Week in pharmacy and
27:12
Speaker 12: I invite people be part of that. We have well
27:16
Speaker 12: the thirty one Day Challenges wrapping up our next event
27:19
Speaker 12: with to help pharmacy leaders improves. That's just a couple
27:24
Speaker 12: of days away, and I would love to have you
27:26
Speaker 12: in that to help you grow those skills so that
27:30
Speaker 12: you can have the impact that I know you want
27:32
Speaker 12: to have on all the people around you. So with that,
27:37
Speaker 12: I would also be curious for this for those of
27:39
Speaker 12: you that have participated in the challenge, and I want
27:41
Speaker 12: you to I've got all sorts of stories that I'll
27:43
Speaker 12: need to share. I'm gonna have to I'm gonna have
27:45
Speaker 12: to write these down, but I'd be really curious to
27:48
Speaker 12: hear from you participant challenger in the thirty one Day Challenge,
27:53
Speaker 12: what has been your favorite challenge so far? And I
27:58
Speaker 12: would love to hear just your success stories and you
28:00
Speaker 12: know some of the impact that some of these challenges
28:02
Speaker 12: have had on you, because I'm going to tell you,
28:05
Speaker 12: I am hard pressed to tell you which one is
28:07
Speaker 12: the best challenge. Each one of those everyone that we
28:10
Speaker 12: had a guest on, those people brought their a game
28:14
Speaker 12: and so I would also encourage you to reach out
28:16
Speaker 12: to those to those guests on the thirty one Day Challenge,
28:20
Speaker 12: let them know that you appreciate just to challenge how
28:23
Speaker 12: they how they pushed you in some way to improve
28:27
Speaker 12: your to improve your skills, to improve your impact that
28:29
Speaker 12: you can have in pharmacy. I think I'm gonna wrap
28:33
Speaker 12: it up there, Todd, thank you so much for giving
28:37
Speaker 12: me this opportunity to share parts of the thirty one
28:40
Speaker 12: day Challenge with this week in Pharmacy audience and on
28:43
Speaker 12: the Pharmacy Podcast Network. And if we are not yet connected,
28:47
Speaker 12: I invite you to connect with me on LinkedIn. That's
28:49
Speaker 12: probably the easiest place to connect with me, and I
28:51
Speaker 12: very much you know, challenge you to recognize that everyone
28:55
Speaker 12: deserves to be led well. And if you don't have
28:57
Speaker 12: that plan to improve your leadership skills, I want to
29:00
Speaker 12: invite you into a community where you can help, where
29:03
Speaker 12: you can get started right away to develop those skills.
29:07
Speaker 12: So with that, Todd, I'm going to wrap up my
29:09
Speaker 12: segment here and I'm going to send it back to you.
29:11
Speaker 12: Thank you, everybody, have a great day.
29:16
Speaker 11: Feeling lost with the complexities of pharmacy accounting.
29:20
Speaker 13: In pharmacy today, there's so many different variables and issues
29:25
Speaker 13: that impact the pharmacy, books, records, accounting, the profitabilities, so
29:29
Speaker 13: or so forth. There's different components of pharmacy that have
29:32
Speaker 13: its own nuances from an accounting standpoint, and so it's tricky,
29:36
Speaker 13: there's no doubt about it.
29:37
Speaker 11: Ready to take your pharmacy to the next level, but
29:40
Speaker 11: don't know where to start. Psychs and Company is here
29:43
Speaker 11: to help, introducing the RX Assessment. With the RX Assessment,
29:47
Speaker 11: the pharmacy CPAs and advisors at PSYCHS will do a
29:50
Speaker 11: deep dive into your accounting and tax situation and give
29:53
Speaker 11: you the action steps you need to take to take
29:56
Speaker 11: your pharmacy to the next level.
29:58
Speaker 13: If you're interested in, you know, working with a team
30:01
Speaker 13: who understands the industry and how the accounting in tax
30:05
Speaker 13: should really be in a pharmacy, this is your chance
30:09
Speaker 13: to get under the hood check of what's going on
30:11
Speaker 13: and getting the feedback of any issues or concerns or
30:14
Speaker 13: again things we think are doing really.
30:16
Speaker 11: Well with get the financial check up your pharmacy needs
30:19
Speaker 11: and head over to Sykes HYPHENCPA dot com or call
30:22
Speaker 11: two five to two four eight two seven six four four.
30:41
Speaker 3: Continuing with the Halloween theme, anybody gets scared when you
30:44
Speaker 3: heard that it's Halloween. Come on, do you have fun?
30:49
Speaker 3: Anybody have any masks out there? Certainly I hope you
30:52
Speaker 3: don't have a mask on while you're driving, unless, of course,
30:55
Speaker 3: it has really good eye holes. Something that's scary to
30:59
Speaker 3: me the continuing beating up of our industry and our
31:04
Speaker 3: pharmacist and our pharmacy owners and the profession.
31:08
Speaker 10: Where was.
31:11
Speaker 3: A podcast I was very excited to get. It was
31:14
Speaker 3: one of the best podcasts we had ever done. It
31:17
Speaker 3: was around Mark Cuban Cost Plus Drugs when they first started,
31:23
Speaker 3: and it was quite amazing to get Alex Oshmowsky, which
31:32
Speaker 3: is doctor Oshmoski, who's the CEO of the Cost Plus Drugs,
31:38
Speaker 3: And it was back in January of twenty twenty one
31:42
Speaker 3: when I had an opportunity to interview him, and it
31:45
Speaker 3: was just phenomenal. Well, we have a post by a
31:48
Speaker 3: close friend of mine, somebody who's a content developer that
31:51
Speaker 3: I look up to. He set the world on fire
31:54
Speaker 3: and podcasting on fire. Matthew Zachary, welcome back to twerks.
31:59
Speaker 5: It is my Todd.
32:01
Speaker 3: It's good to have you. I tell you what. This
32:03
Speaker 3: post that you put out is currently on fire. If
32:07
Speaker 3: you haven't read this you definitely if you're on LinkedIn,
32:10
Speaker 3: you have to get on LinkedIn look for Matthew Zachary
32:16
Speaker 3: z A C h A R Y Matthew Zachary and
32:20
Speaker 3: you'll see a post that he has out there that
32:23
Speaker 3: is about Mark Cuban getting an opportunity to talk to
32:26
Speaker 3: lobbyists in Congress and getting deeper into the truth about
32:34
Speaker 3: PBMs and how they've, for lack of a better term,
32:38
Speaker 3: and it's a horrible term, but they've they've raped the
32:41
Speaker 3: profession of pharmacy in many many ways and destroyed businesses
32:45
Speaker 3: and destroyed lives and didn't give the coverage that they
32:49
Speaker 3: wanted to, and it's really just about profit. And Mark
32:52
Speaker 3: is taking a position that he started a long, long
32:55
Speaker 3: time ago. Like I said twenty twenty one, I think
32:59
Speaker 3: Alex you know, was just starting up. And now this
33:02
Speaker 3: organization is not only is catching fire for him personally
33:06
Speaker 3: and his continuing success, but more importantly, it's trickling over
33:11
Speaker 3: into exposing what these PBMs have been doing. And I
33:15
Speaker 3: read your article and I just think it was absolutely fascinating,
33:18
Speaker 3: and so did three hundred thousand other people who have
33:23
Speaker 3: looked at this post. I can't believe how popular. There's
33:25
Speaker 3: almost a half million impressions, so that's incredible.
33:29
Speaker 10: I was not expecting the response to this. I mean,
33:35
Speaker 10: people like me not usually talking about Mark Cuban. We're
33:38
Speaker 10: living in the trenches of just trying to patch holes
33:41
Speaker 10: in the dam and make sure people are not nearly
33:44
Speaker 10: as screwed by the system as they are currently. But
33:48
Speaker 10: I've been listening to him. Honestly, I love that your show.
33:52
Speaker 10: I listened to your I was your listener on the
33:55
Speaker 10: show with cost plus and just getting a sense of
33:59
Speaker 10: his concers side, not his Wall Street Dallas Maverick's side.
34:05
Speaker 10: I'm convinced he has no idea what the downstream effect
34:09
Speaker 10: is of his calling bullshit out on industry. He doesn't
34:13
Speaker 10: understand the impact it is having in the patient advocate
34:18
Speaker 10: and the enterprise patient advocate space. So I just had
34:22
Speaker 10: to chime in after I watched his testimony calling bullshit
34:27
Speaker 10: on these PBMs that are harming Americans every possible way
34:32
Speaker 10: they can, more than the other systems are trying to
34:34
Speaker 10: harm patients, and I just leaned into what he said,
34:39
Speaker 10: and I said, you are becoming the patron saint of
34:41
Speaker 10: patients without realizing what the hell you're doing. So let's
34:45
Speaker 10: stop solely focusing on the growth gains and the market
34:51
Speaker 10: shifting and the opinions on Wall Street and look at
34:54
Speaker 10: what the American citizens can get out of the fact
34:56
Speaker 10: that you are doing this. And sure enough, actually I
35:00
Speaker 10: put the right AI image up with the right tone.
35:03
Speaker 10: I tagged No. One in the post, and it just
35:06
Speaker 10: became my most viral content on LinkedIn in twenty years.
35:11
Speaker 3: Yeah, it's amazing, and it brought a lot of attention
35:14
Speaker 3: to some of the organizations and people that have now
35:19
Speaker 3: engaged and have read it. I've heard from one of
35:22
Speaker 3: my clients that read it. A very important client to
35:25
Speaker 3: us that is in the heart of independent community pharmacy,
35:28
Speaker 3: which is the independent Pharmacy Cooperative, was educating them Matthew
35:34
Speaker 3: on the importance of being involved in HLTCH or some
35:37
Speaker 3: people say health going and they met weight watchers, and
35:43
Speaker 3: they met Best by Health, and they met payers and
35:46
Speaker 3: big companies and independent pharmacy. Up until last year, never
35:50
Speaker 3: had an organization that said, hey, here's a bunch of
35:53
Speaker 3: privately pharmacy owners that are also involved in this bigger ecosystem.
35:58
Speaker 3: I was very and I think Alex the CEO of
36:03
Speaker 3: Cost Plus Drugs I think he holds this against me
36:06
Speaker 3: because I haven't gotten any follow up on that podcast
36:09
Speaker 3: for the last four years. So this is a mistake
36:12
Speaker 3: that I made and being too harsh. But in the beginning,
36:16
Speaker 3: when they were starting this whole cost plus drugs, I
36:19
Speaker 3: did not trust Mark Cuban, you know, as a humanitarian,
36:24
Speaker 3: and he really is. And I want to apologize in
36:27
Speaker 3: the way that I handled that originally, just publicly, and
36:30
Speaker 3: what I said was this is just a ploy and
36:33
Speaker 3: just a strategy to try to get into the market
36:36
Speaker 3: of pharmaceutical distribution in pharmacy, just like Amazon, just like
36:41
Speaker 3: and I was kind of mad about it, and I said,
36:43
Speaker 3: the only way that you could prove to me that
36:46
Speaker 3: this was super sincere and looking out for what's the
36:50
Speaker 3: best in the whole ecosystem doesn't mean you can't make profit.
36:53
Speaker 3: Of course, you know, make some profit, but not at
36:56
Speaker 3: the volume of what PBMs are doing. But I said,
36:58
Speaker 3: the only way that he could prove this to me
37:00
Speaker 3: is if they embraced independent community pharmacy and teamed up
37:04
Speaker 3: with them to assure that the communities that they're trying
37:08
Speaker 3: to literally save because it's the only provider of healthcare
37:12
Speaker 3: in the entire twenty mile radius in the middle of Buntuck,
37:16
Speaker 3: you know, Orlando or I want to go to talk
37:21
Speaker 3: where the hell is But I'm just saying it's It
37:24
Speaker 3: was frustrating me because I thought it was a mega move,
37:27
Speaker 3: a mega profit move again, and now I know it wasn't.
37:31
Speaker 3: And I want to be And he's a badass, and
37:34
Speaker 3: and he's using his he doesn't I don't even think
37:37
Speaker 3: he not that he doesn't care about money. I'm sure
37:39
Speaker 3: he does, but I don't think this is really that.
37:41
Speaker 3: That's not his foot and I'm looking at your post
37:44
Speaker 3: and his foot sticking out, so it makes sense to
37:47
Speaker 3: say that. But I don't think he's stepping on on
37:51
Speaker 3: into the into the pharmacy sector. It wasn't about being profitable.
37:56
Speaker 3: It was about, hey, we could do this and still
37:59
Speaker 3: make money much as they are. It's just a flat
38:01
Speaker 3: fee and it's you know, but I wanted them to
38:04
Speaker 3: embrace independent community pharmacy. And guess what. He has shown
38:07
Speaker 3: up in the space of privately owned pharmacy now several times,
38:12
Speaker 3: including on a podcast with one of my clients called
38:15
Speaker 3: Psychs and Company. And now I'm like, I have all
38:18
Speaker 3: the respect in the world for him, because he's come
38:20
Speaker 3: full circle in realizing that we have to do this together,
38:25
Speaker 3: hospital systems and specialty pharmacy, which I know you don't
38:28
Speaker 3: like that word, community pharmacy, independence, even our chains. We
38:33
Speaker 3: have to show up and we have to work together,
38:35
Speaker 3: and he's ready to do that. I really believe he.
38:37
Speaker 10: Is the answer to all of that is absolutely yes.
38:43
Speaker 10: I don't know if you should apologize. I think it's
38:45
Speaker 10: good to be skeptical at the start and then let
38:50
Speaker 10: them prove themselves afterwards, believing in good intentions. It should
38:54
Speaker 10: be earned, not automatically given. So forgive yourself for to
39:00
Speaker 10: apologize to them. We should be angry and skeptical. Well,
39:03
Speaker 10: here's another for profit scandal going to rape the country. No,
39:07
Speaker 10: prove yourself that you're better than everything else, and they
39:09
Speaker 10: did just that. I have been very reserved in chiming
39:13
Speaker 10: in on what Cuban's attentions have been, but his testimony
39:18
Speaker 10: was just scathing against fraud, waste, and abuse, which apparently
39:23
Speaker 10: are the terms these days we're supposed to use. But
39:26
Speaker 10: this is truly where it actually is. There is no
39:30
Speaker 10: need for these middlemen to exist in our country. There
39:33
Speaker 10: is no economic gain to citizens for this to exist
39:36
Speaker 10: in our country. This is harm. This is nothing more
39:39
Speaker 10: than harm to Americans that this exists. So I will
39:45
Speaker 10: worry it. I don't believe he truly understands the depth,
39:50
Speaker 10: breadth and heft of the impact, reputation and the patron sainthoodness.
39:57
Speaker 10: If I could go in a therm that he's downstream
40:00
Speaker 10: to the average citizen, and he has an opportunity to
40:04
Speaker 10: engage with the average citizen now to understand what we
40:08
Speaker 10: need to get done, to support what he needs to
40:10
Speaker 10: get done. It's finally a billionaire on the side of
40:13
Speaker 10: consumer protection.
40:16
Speaker 3: Yeah, and the timing couldn't be better, Matthew, because the
40:21
Speaker 3: back of the backs are being broken of these big
40:25
Speaker 3: three PBMs who thought they were constantly staying one step
40:30
Speaker 3: ahead of the lawyers and spending multi billions of dollars
40:34
Speaker 3: in lobbying, and when the NCPA was like a fraction
40:37
Speaker 3: of that being able to lobby, And now the ten
40:42
Speaker 3: percent of the total pie of all this lobbying money
40:45
Speaker 3: is finally seeping into the cracks that have been created
40:50
Speaker 3: now to have someone at his level from a public perspective,
40:55
Speaker 3: bringing attention to it. It's that final boss in the
40:59
Speaker 3: video game that you come up again and the last level, Yes, exactly,
41:05
Speaker 3: and the big boss is Mark Cuban. So yeah, I mean,
41:09
Speaker 3: I'm going to do everything I can to connect people
41:11
Speaker 3: to listening to this from the consumer perspective and letting
41:14
Speaker 3: them understand PBMs are are purposely confusing that they do
41:20
Speaker 3: not want the public to understand what they do with
41:22
Speaker 3: tax money and with money that your grandmother desperately needs
41:26
Speaker 3: to cover her meds and she can't because she can't
41:29
Speaker 3: afford it anymore. And it's all being sucked sucked up
41:32
Speaker 3: into the vacuum of profit. And they didn't even go
41:36
Speaker 3: to they didn't even do a good job in the
41:38
Speaker 3: last three years hiding it. And when these analysts, drug
41:43
Speaker 3: channels and you know and three three something advisors, Antonio
41:51
Speaker 3: Chucha and all these people that were the insiders, They've
41:54
Speaker 3: been chiming on this for ten years. You have been
41:57
Speaker 3: chiming on it for twenty years, and now a sudden
42:01
Speaker 3: all of this chipping away. It's I'm finally at a
42:04
Speaker 3: place in my twenty two year career in pharmacy where
42:08
Speaker 3: I see major things taking place and changes happening.
42:12
Speaker 10: Yeah, at the end of the day, you know, I've
42:16
Speaker 10: been trickling out very slowly to the industry, but I've
42:18
Speaker 10: been fermenting for the last year and a half, which
42:20
Speaker 10: is the very idea. It basically flies in the face
42:23
Speaker 10: of what we have been calling patient advocacy for twenty
42:26
Speaker 10: five years, which is we are always on the defensive
42:30
Speaker 10: on the receiving end of fuckery, and we have to
42:33
Speaker 10: just take it and hope Hill they solves a problem
42:35
Speaker 10: with a state reconciliation budget that works with either HIPPO
42:39
Speaker 10: or the FDA or OCS or CMS or whatever it is,
42:45
Speaker 10: and that like our voice is met or I don't
42:47
Speaker 10: believe that exists anymore. I don't think our voice is
42:49
Speaker 10: matter at all. You've never had power. We've always been
42:53
Speaker 10: on the defensive. And what is going to give Americans power,
42:57
Speaker 10: not just patients, pharmacists, men profess. What is going to
43:01
Speaker 10: give us power is voting. And until now, we've never
43:05
Speaker 10: had the opportunity to be considered an electorate, to be
43:09
Speaker 10: considered a voter block. There's never been anything in this
43:12
Speaker 10: country that equivoc caps to our planned parenthood or the
43:16
Speaker 10: NRA for patient rights. It's nice to write up a
43:19
Speaker 10: patient manifesto or a cancer patient rights thing nothing matters
43:23
Speaker 10: unless Ita hays the teeth of the fear of getting elected.
43:28
Speaker 10: And at the end of the day, that is what
43:29
Speaker 10: I've been building, and I'm happy to reveal a little
43:31
Speaker 10: more breadcrumbs here on your show.
43:34
Speaker 8: Well, I love it.
43:35
Speaker 3: I mean, dive into some of the things you're kind
43:38
Speaker 3: of setting stage because you've given me a preview of
43:41
Speaker 3: twenty twenty six. And I want to be a part.
43:44
Speaker 3: I mean, I want us all to be a part.
43:45
Speaker 3: I want as many pharmacists and pharmacy professionals to be
43:49
Speaker 3: a part of it. I think it's fascinating.
43:51
Speaker 10: Well, the teaser is it's called We the Patients. It's
43:55
Speaker 10: wethepatients dot org, not dot com. Don't search for it.
43:59
Speaker 10: We're not on SEO, would Google yet, but just like
44:02
Speaker 10: way Thepatients dot organ your browser or whatever, and you'll
44:04
Speaker 10: see what we're up to. We're not quite read like
44:06
Speaker 10: Second City, not quite ready for primetime. But at the
44:09
Speaker 10: end of the day, no one has ever organized the
44:13
Speaker 10: patient community, the cancer community, the medical community into a
44:17
Speaker 10: voter block. The question is, once we're formed as a
44:20
Speaker 10: voter block, what do we want Because then we get
44:24
Speaker 10: to write the laws, we get to get the hill days,
44:26
Speaker 10: we get to talk to our elected officials. We get
44:29
Speaker 10: to groom candidates and endorse candidates like any other pack
44:32
Speaker 10: would do. And I believe the first step here is
44:36
Speaker 10: to look at the simplest solution that is pro corporate,
44:39
Speaker 10: which is consumer protection loans that the states that ban
44:43
Speaker 10: patients from getting abused by the system in a way
44:46
Speaker 10: that saves the state money while at the santem also
44:50
Speaker 10: benefits the payer industry and eliminates middlemen. So we are
44:55
Speaker 10: looking at consumer protection laws at the state level that
44:59
Speaker 10: manned health economic benefits by doing X, Y and z
45:03
Speaker 10: to benefit patients and providers in that state. And this
45:07
Speaker 10: is unprecedented in American history. No one has ever put
45:12
Speaker 10: together an organized voter block of millions of Americans on
45:16
Speaker 10: the single most bipartisan purple issue in America. Should anyone
45:21
Speaker 10: die because United Healthcare says no?
45:25
Speaker 12: Yeah?
45:26
Speaker 3: Bill Schmidtnick has been on the show several times and
45:28
Speaker 3: the loss of his son, Cole, he lost because of
45:32
Speaker 3: a PBM way of doing business. And if that would
45:38
Speaker 3: have been, you know, in the hands of a of
45:41
Speaker 3: a non change publicly traded pharmacy, if it would have
45:45
Speaker 3: been in the hands of an independent Cole would still
45:47
Speaker 3: be here because that independent would have said, hey, here's
45:49
Speaker 3: you're Inhaler. We're going to get this taken care of
45:51
Speaker 3: later because your insurance is really jacked up right now,
45:54
Speaker 3: we'll follow up with it. And that's not what happened.
45:57
Speaker 3: And to have that happen, and to know now somebody
46:01
Speaker 3: that I now consider a friend and we were we
46:03
Speaker 3: did some some recordings and him and his family are
46:08
Speaker 3: now deep into pharmacy transformation and PBM reform And why
46:12
Speaker 3: does it take that? Why does it Why do things
46:15
Speaker 3: like that have to happen to get things to change,
46:18
Speaker 3: And it's just dumb. So I mean, it's it's great
46:22
Speaker 3: that you're involved in it because if we have additional
46:25
Speaker 3: hammers in this fight, I want the m z U
46:29
Speaker 3: the mz hammer coming down uh in helping because you've
46:32
Speaker 3: brought so many voices, uh, for purpose and for traction
46:37
Speaker 3: and for everything from that patient's perspective of what you
46:40
Speaker 3: went through with your own cancer survival and now you
46:44
Speaker 3: know it's it's spreading. So this is the perfect time
46:47
Speaker 3: to be a part of this.
46:49
Speaker 10: Yeah. So the breadcrumb ask of your viewers and your
46:52
Speaker 10: listeners and your network is to get ready for America
46:56
Speaker 10: to transform next year for the first time in history
47:00
Speaker 10: and create a voter block of millions that are going
47:04
Speaker 10: to demand protections and not reconciliations, and we meet it.
47:09
Speaker 10: We have teeth, which is as a cheche terminal use
47:13
Speaker 10: very sparingly. We have teeth, and we can be an electorate.
47:17
Speaker 10: We can be surveying and studying and polling and ask
47:20
Speaker 10: questions and write laws and talk to our elected officials
47:24
Speaker 10: like we have power. And this is not like a
47:27
Speaker 10: twenty six twenty eight thirty. This is mid year ballots
47:32
Speaker 10: that get put up there with sponsors who want to
47:35
Speaker 10: get re elected based on specific single issues. This is
47:40
Speaker 10: really happening right now, and we're not pulling a trigger yet.
47:44
Speaker 10: We are asking people to basically eat the breadcrumbs, get
47:49
Speaker 10: a sense of what this is going to be, and
47:52
Speaker 10: want to attach themselves to a movement that's never existed before.
47:57
Speaker 3: It's awesome. It's awesome. We'll be helping out hope to
48:01
Speaker 3: have you back on twerks and we'll have a couple
48:05
Speaker 3: pharmacy industry professionals participating in the discussion around what this
48:10
Speaker 3: means for.
48:10
Speaker 10: Health and Mark Cuban Mark if you're listening get on
48:14
Speaker 10: back to bandwagon.
48:16
Speaker 3: That's right. Come on twerks, Yes, come on ts Hey,
48:21
Speaker 3: We'll be right back with Mark twers Matthew. Thank you
48:24
Speaker 3: so much for this time my pleasure.
48:26
Speaker 10: Thank you, tud.
48:36
Speaker 11: This episode is sponsored by Independent Pharmacy Cooperative, widely known
48:40
Speaker 11: as IPC. Established in nineteen eighty three, IPC is the
48:43
Speaker 11: nation's largest group purchasing organization owned by independent pharmacy with
48:48
Speaker 11: a mission of maximizing the success of community pharmacists. IPC
48:52
Speaker 11: works to provide members with access to effective programs and
48:55
Speaker 11: services designed to enhance profitability for independent pharmacy. Read more
49:00
Speaker 11: about our mission by checking out our website at ipc
49:03
Speaker 11: our x dot com. That's ipcrx dot com.
49:20
Speaker 3: This has been a fun episode for me. I want
49:23
Speaker 3: to thank you so much for listening. And before you go,
49:28
Speaker 3: I want you to think about something. I want you
49:30
Speaker 3: to think about the impact that you're actually having on
49:33
Speaker 3: people's lives. You are having impact on people who need
49:38
Speaker 3: you right now. Our government, why is it always so
49:42
Speaker 3: jacked up? Our government just seems to always shortfall the people,
49:49
Speaker 3: and especially the people that are paying all the taxes,
49:51
Speaker 3: like me paying all those taxes. So we have to
49:55
Speaker 3: pick up the slack. I have to pick up the slack.
49:57
Speaker 3: We have to think of how do we use this
50:00
Speaker 3: network to get to physicians, how do we get this
50:03
Speaker 3: network and supporting insurance companies who are doing the right thing,
50:07
Speaker 3: and they're out there, independent, independently owned PBMs, these transparent PBMs.
50:13
Speaker 3: They're literally changing how healthcare, more specifically, how pharmacy care
50:20
Speaker 3: can get paid for and the future of what that
50:23
Speaker 3: means for the role of the pharmacist and disease state management.
50:27
Speaker 3: And thanks for IPC. By the way, IPC has that
50:31
Speaker 3: platform out called I Care Plus and it's helping pharmacies
50:36
Speaker 3: and pharmacists more importantly pharmacists to get paid for your
50:40
Speaker 3: services that have nothing to do with a dispensing fee.
50:44
Speaker 3: This is huge. This is where this industry's going. I
50:48
Speaker 3: predict within the next three to five years more than
50:55
Speaker 3: seventy percent maybe maybe more closer to eighty percent of
51:00
Speaker 3: the money that our pharmacists are making are going to
51:03
Speaker 3: be tied to the treatment and the treatment programs and
51:08
Speaker 3: the follow up in the assurance that the medications are
51:11
Speaker 3: working as intended and then being able to suggest pivots
51:15
Speaker 3: to the physician and the physician team and sometimes just
51:19
Speaker 3: based on their knowledge making the switch, especially if it's
51:24
Speaker 3: going to save a life and you know that those
51:26
Speaker 3: things happen. Excuse me, what a day, What a day
51:31
Speaker 3: to be alive, What a day to be in pharmacy.
51:33
Speaker 3: I thank you for all of your work. I do
51:36
Speaker 3: want you to be aware of something. We have some
51:39
Speaker 3: new episodes that came out. Shout out to doctor Mark Garafully,
51:43
Speaker 3: the pain Guy. Mark is amazing. He's an amazing podcaster.
51:48
Speaker 3: Check him out at pain guy dot us once again,
51:52
Speaker 3: that's pain guy dot us or his podcast, pain pod
51:59
Speaker 3: dot Us. That's pain pod dot us. The US stands
52:03
Speaker 3: for us, that's you and I, that's us. We are
52:06
Speaker 3: in US and his pain management expertise is just out
52:11
Speaker 3: of this world and he's fun to listen to. Take
52:13
Speaker 3: a listen to hey new Pediatric Pharmacist Review, one of
52:17
Speaker 3: the hottest podcasts in the network and in pharmacy overall
52:22
Speaker 3: in all of twenty twenty five. We can't wait to
52:25
Speaker 3: talk to you more about this, but take a listen
52:27
Speaker 3: to the kids list low down the latest from the
52:32
Speaker 3: Pediatric Pharmacist Review. We also dropped our final episode of
52:37
Speaker 3: the coverage of the National Association of Specialty Pharmacies twenty
52:41
Speaker 3: twenty five coverage of their show, The Expo was absolutely
52:46
Speaker 3: phenomenal time together in what's happening in specialty pharmacy. If
52:50
Speaker 3: you're curious about specialty pharmacy and you want to listen
52:53
Speaker 3: to the insiders talk about where the entire profession's going
52:58
Speaker 3: and how important education is and how important expertise is
53:03
Speaker 3: from our pharmacists in these specialty tracks. So take a
53:07
Speaker 3: listen to that. We are doing so much with the
53:11
Speaker 3: associations right now. A shout out to the NCPA and
53:15
Speaker 3: the APHA and the APC and the NASP and the ASCP, NACDS.
53:22
Speaker 3: I mean so much awfua betsuit. But these organizations are
53:27
Speaker 3: bringing us together and empowering us and making us stronger.
53:31
Speaker 3: Our publication, our network is an overlay of one hundred
53:36
Speaker 3: percent of those and if you want to take advantage
53:39
Speaker 3: of what we do and who we're connected to, eighty
53:42
Speaker 3: thousand downloads per month, thousands and thousands of listeners. We
53:47
Speaker 3: see the public starting to ask questions. This is an
53:51
Speaker 3: opportunity to take this network to an entire new level.
53:55
Speaker 3: And I'm talking about iHeartMedia partnerships and I'm talking about
54:00
Speaker 3: SERIOUSXM partnerships, and I'm talking about leveraging, and I'm talking
54:04
Speaker 3: about bringing pharmacists to these voice to the ears of
54:08
Speaker 3: our consumers. And if you want to be a part
54:11
Speaker 3: of that, if you want to dig in and really
54:13
Speaker 3: build this, because I'm gonna keep going. I'm gonna do
54:16
Speaker 3: this to the day to day because I'm on fire
54:20
Speaker 3: right now. We're on fire right now. This profession is
54:23
Speaker 3: going through a massive change. I'm so proud to be
54:26
Speaker 3: a part of it. I'm so proud to serve you.
54:29
Speaker 3: That's who I am, That's what we are here at
54:31
Speaker 3: the Pharmacy Podcast Network. How can we work with you
54:35
Speaker 3: in your organization and your people, your association, your passion
54:39
Speaker 3: as a pharmacist. How can I work with you and
54:41
Speaker 3: make things better for people and for people's lives out
54:44
Speaker 3: there who deserve the best pharmacy care. Hey, it's been
54:50
Speaker 3: wonderful to spend the time with you here on twerks.
54:54
Speaker 3: Please share, Please subscribe, Please tell another pharmacist, tell a
54:58
Speaker 3: physician of about what we're doing, and have them come
55:02
Speaker 3: on create a show with me. Hope you have a
55:05
Speaker 3: wonderful weekend and a very happy Halloween twenty twenty five
55:09
Speaker 3: o